Characterization of clinical multidrug-resistant Escherichia coli and Klebsiella pneumonia isolates, 2007-2009, China

Microbial Drug Resistance

Volumn 18, Issue 5, 2012, Pages 465-470

  Zhang, Youjiang ^a   Yang, Jiyong ^a   Ye, Liyan ^a   Luo, Yanping ^a   Wang, Weiwei ^b   Zhou, Wei ^c   Cui, Zhigang ^d   Han, Li ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Center for Hospital Infection Control   (China)

^c BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFOTAXIME; CIPROFLOXACIN;

16S RRNA METHYLASE GENE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BETA LACTAMASE GENE; CHINA; DNA SEQUENCE; ESCHERICHIA COLI; GENE MUTATION; GYRA GENE; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PHYLOGENY; PLASMID MEDIATED QUINOLONE RESISTANCE GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; QUINOLONE RESISTANCE DETERMINING REGION GENE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHINA; CONJUGATION, GENETIC; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; PREVALENCE; TERTIARY HEALTHCARE;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 84866487070     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2012.0016     Document Type: Article

References (33)

1. An, M.M., Z. Zou, H. Shen, J.D. Zhang, M.L. Chen, P. Liu, R. Wang, and Y.Y. Jiang. 2009. Ertapenem versus piperacillin/ tazobactam for the treatment of complicated infections: a metaanalysis of randomized controlled trials. BMC Infect. Dis. 9:193.
2. Bush, K., and G.A. Jacoby. 2010. Updated functional classification of beta-lactamases. Antimicrob. Agents Chemother. 54:969-976.
3. Cattoir, V., L. Poirel, V. Rotimi, C.J. Soussy, and P. Nordmann. 2007.Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J. Antimicrob. Chemother. 60:394-397. (Pubitemid 47243891)
4. Cesaro, A., R.R. Bettoni, C. Lascols, A. Merens, C.J. Soussy, and E. Cambau. 2008. Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmidborne qnr genes. J. Antimicrob. Chemother. 61:1007-1015. (Pubitemid 351524440)
5. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
6. [CLSI] Clinical and Laboratory Standards Institute. 2010. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (M100-S20). Vol.30 No.1. 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA.
7. Dallenne, C., A. Da Costa, D. Decre, C. Favier, and G. Arlet. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65: 490-495.
8. Doi, Y., and Y. Arakawa. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis. 45:88-94. (Pubitemid 46984623)
9. Everett, M.J., Y.F. Jin, V. Ricci, and L.J. Piddock. 1996. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40:2380-2386. (Pubitemid 26328050)
10. Gaynes, R., and J.R. Edwards. 2005. Overview of nosocomial infections caused by gram-negative bacilli. Clin. Infect. Dis. 41:848-854. (Pubitemid 41266753)
11. Ho, J., P.A. Tambyah, and D.L. Paterson. 2010. Multiresistant gram-negative infections: a global perspective. Curr. Opin. Infect. Dis. 23:546-553.
12. Hoban, D.J., S.K. Bouchillon, S.P. Hawser, and R.E. Badal. 2010. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diagn. Microbiol. Infect. Dis. 66:78-86.
13. Jacoby, G.A. 2009. AmpC beta-lactamases. Clin. Microbiol. Rev. 22:161-182, Table of Contents.
14. Jana, S., and J.K. Deb. 2006. Molecular understanding of aminoglycoside action and resistance. Appl. Microbiol. Biotechnol. 70:140-150.
15. Kim, H.B., C.H. Park, C.J. Kim, E.C. Kim, G.A. Jacoby, and D.C. Hooper. 2009. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob. Agents Chemother. 53:639-645.
16. Li, D.X., S.M. Zhang, G.Z. Hu, Y. Wang, H.B. Liu, C.M. Wu, Y.H. Shang, Y.X. Chen, and X.D. Du. 2011. Tn3-associated rmtB together with qnrS1, aac(6′)-Ib-cr and blaCTXM-15 are co-located on an F49:A-:B-plasmid in an Escherichia coli ST10 strain in China. J. Antimicrob. Chemother. 67:236-238.
17. Luo, Y., J. Yang, Y. Zhang, L. Ye, L. Wang, and L. Guo. 2011. Prevalence of beta-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance determinants. Int. J. Antimicrob. Agents 37:352-355.
18. Martinez-Martinez, L., M. Eliecer Cano, J. Manuel Rodriguez-Martinez, J. Calvo, and A. Pascual. 2008. Plasmidmediated quinolone resistance. Expert Rev. Anti. Infect. Ther. 6:685-711.
19. Park, C.H., A. Robicsek, G.A. Jacoby, D. Sahm, and D.C. Hooper. 2006. Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 50:3953-3955. (Pubitemid 44684926)
20. Pfeifer, Y., A. Cullik, and W. Witte. 2010. Resistance to cephalosporins and carbapenems in gram-negative bacterial pathogens. Int. J. Med. Microbiol. 300:371-379.
21. Ribot, E.M., M.A. Fair, R. Gautom, D.N. Cameron, S.B. Hunter, B. Swaminathan, and T.J. Barrett. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-67.
22. Rodriguez-Bano, J., and A. Pascual. 2008. Clinical significance of extended-spectrum beta-lactamases. Expert Rev. Anti. Infect. Ther. 6:671-683.
23. Torres, C.,M.H. Perlin, F. Baquero, D.L. Lerner, and S.A. Lerner. 2000. High-level amikacin resistance in Pseudomonas aeruginosa associated with a 3′-phosphotransferase with high affinity for amikacin. Int. J. Antimicrob. Agents 15: 257-263. (Pubitemid 30618784)
24. Toth, M., H. Frase, J.W. Chow, C. Smith, and S.B. Vakulenko. 2010. Mutant APH(2)-IIa enzymes with increased activity against amikacin and isepamicin. Antimicrob. Agents Chemother. 54:1590-1595.
25. Tran, J.H., G.A. Jacoby, and D.C. Hooper. 2005. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob. Agents Chemother. 49:118-125. (Pubitemid 40065781)
26. Tran, J.H., G.A. Jacoby, and D.C. Hooper. 2005. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob. Agents Chemother. 49:3050-3052. (Pubitemid 40917639)
27. Vergidis, P.I., and M.E. Falagas. 2008. Multidrug-resistant gram-negative bacterial infections: the emerging threat and potential novel treatment options. Curr. Opin. Investig. Drugs 9:176-183. (Pubitemid 351206376)
28. Wang, H., M. Chen, Y. Ni, Y. Liu, H. Sun, Y. Yu, X. Yu, Y. Mei, M. Liu, Z. Sun, et al. 2010. Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS), 2003-2008. Int. J. Antimicrob. Agents 35:227-234.
29. Xia, Q., H. Wang, A. Zhang, T. Wang, and Y. Zhang. 2011. Prevalence of 16S rRNA methylase conferring high-level aminoglycoside resistance in Escherichia coli in China. Int. J. Antimicrob. Agents 37:387-388.
30. Xiao, Y.H., C.G. Giske, Z.Q. Wei, P. Shen, A. Heddini, and L.J. Li. 2011. Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist. Updates 14:236-250.
31. Yang, J., Y. Luo, S. Cui, W. Wang, and L. Han. 2011. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants. Microb. Drug Resist. 17:363-367.
32. Yang, J., Y. Luo, J. Li, Y. Ma, C. Hu, S. Jin, L. Ye, and S. Cui. 2010. Characterization of clinical Escherichia coli isolates from China containing transferable quinolone resistance determinants. J. Antimicrob. Chemother. 65:453-459.
33. Yang, J., L. Ye, W. Wang, Y. Luo, Y. Zhang, and L. Han. 2011. Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates. Int. J. Antimicrob. Agents 38:348-351.